Reid Robison

Reid Robison is an American data scientist and a physician. He is the CEO and co-founder of Tute Genomics. He is most notable for his contributions in healthcare technology start-ups and humanitarian work.[1]

Education and Career

Robison earned a bachelor's degree from Brigham Young University in Provo, UT before attending the University of Utah School of Medicine in Salt Lake City, UT, where he earned a dual MD/MBA. He then completed psychiatry residency training followed by fellowship training in genetics and bioinformatics at the University of Utah. In his early career he held a faculty position at the University of Utah and co-directed the molecular genetics lab where he focused his research primarily on the genetic associations of autism,[2][3][4][5] and ADHD,[6][7] and also contributed to the discovery of Ogden Syndrome. During his time on faculty within the Department of Psychiatry he also led global health initiatives and guided trainees during trips to underserved locations such as Haiti, Ghana and refugee camps along the Thai/Burma border.[1]

Robison is the founder of the Polizzi Foundation, a free clinic based in Salt Lake City offering mental health services to the uninsured.[8] He, along with Clark W Johnson MD, his medical school colleague and business partner, were co-founders of Clinical Methods, a center for clinical trials which was acquired in 2012 by CRI Lifetree.[9] In 2012, Robison co-founded Tute Genomics and currently holds the position of CEO.

Robison was named one of the top 40 healthcare transformers,[10] and one of the Utah Venture Entrepreneur Forum peak 100 entrepreneurs in 2014.[11]

Robison is also known for his use of google fiber to speed up genomic data transfer & analysis.[12][13]

References

  1. 1 2 "Creating the "Dropbox of your Genome": Reid Robison Interview". datascienceweekly.org. Retrieved 30 May 2015.
  2. ↑ Allen-Brady K, Cai G, Cannon D, Robison R, McMahon WM, Coon H, Buxbaum JD. Autism Res. 2011 Aug;4(4):293-6. doi: 10.1002/aur.195. Epub 2011 Apr 12
  3. ↑ Coon, H, Villalobos, ME, Robison, RJ, Camp, NJ, Cannon, DS, Allen-Brady, K, Miller JS and McMahon WM. Mol Autism. 2010 Apr 8;1(1):8. doi: 10.1186/2040-2392-1-8
  4. ↑ Cannon DS, Miller JS, Robison RJ, Villalobos ME, Wahmhoff NK, Allen-Brady K, McMahon WM, Coon H. Mol Autism. 2010 Feb 22;1(1):3. doi: 10.1186/2040-2392-1-3
  5. ↑ Allen-Brady K, Cannon D, Robison R, McMahon WM, Coon H. Autism Res. 2010 Apr;3(2):47-52. doi: 10.1002/aur.119
  6. ↑ Reimherr F, Marchant B, Olsen JH, Wender PH, Robison RJ. Journal of Attention Disorders February 2013 vol. 17 no. 2 102-113
  7. ↑ Marchant B, Reimherr FW, Halls C, Williams ED, Strong ED, Kondo D, Soni P, Robison RJ. ADHD Attention Deficit and Hyperactivity Disorders 03/2011; 3(3):237-44
  8. ↑ "SelectHealth Announces This Year's Select 25 Award Winners". selecthealth.org. Retrieved 30 May 2015.
  9. ↑ "Clinical Methods - Company details". crunchbase.com. Retrieved 30 May 2015.
  10. ↑ "The Top 40 Healthcare Transformers". mmm-online.com. Retrieved 30 May 2015.
  11. ↑ "2014 Peak 100 Winners". uvef.com. Retrieved 30 May 2015.
  12. ↑ "Fiber cuts wait for health test results". tennessean.com. Retrieved 30 May 2015.
  13. ↑ "How Google Fiber is changing the game for genomics". medium.com. Retrieved 30 May 2015.
This article is issued from Wikipedia - version of the 9/12/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.